| 1. | Arroyo V, Gines P, Gerbes AL et al.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996: 23: 164–176. MEDLINE |
| 2. | Banares R, Casado M, Rodriguez-Laiz JM et al.: Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998; 93: 75–79. MEDLINE |
| 3. | Barange K, Peron J-M, Imani K et al.: Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139–1143. MEDLINE |
| 4. | Benner KG, Sahagun G, Saxon R et al.: What predicts survival and resolution of refractory ascites after TIPS? Hepatology 1996; 24: 449A. |
| 5. | Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T: Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. Hepatology 1997; 25: 63–70. MEDLINE |
| 6. | Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T: Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. J Hepatol 1997; 26: 312–324. MEDLINE |
| 7. | Bernard B, Grange J-D, Khac EN, Amiot X, Opolon P, Poynard T: Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology 1999; 29: 1655–1661. MEDLINE |
| 8. | Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU et al.: Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288–295. MEDLINE |
| 9. | Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H et al.: Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 2002; 14: 723–731. MEDLINE |
| 10. | Brensing KA, Hörsch M, Textor J, Schiedermaier P, Raab P, Schepke M et al.: Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt. Scand J Gastroenterol 2002; 37: 1070–1076. MEDLINE |
| 11. | Burchell AR, Rousselot LM, Panke WF: A seven-year experience with side-to-side portacaval shunt for cirrhotic ascites. Ann Surg 1968; 168: 655–670. MEDLINE |
| 12. | Burroughs AK, Hons ChB, Patch D: Transjugular intrahepatic portosystemic shunt. Seminars in Liver Disease 1999; 19: 457–473. MEDLINE |
| 13. | Burroughs AK, Vangeli M: Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: Randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 2002; 37: 249–252. MEDLINE |
| 14. | Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Rodriguez SR et al.: Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996; 110: 832–839. MEDLINE |
| 15. | Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan DR et al.: Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. Ann Intern Med 1997; 126: 858–865. MEDLINE |
| 16. | Chalasani N, Clark WS, Martin LG et al.: Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118: 138–144. MEDLINE |
| 17. | Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. „Salvage“ transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981–987. MEDLINE |
| 18. | Crenshaw WB, Gordon FD, Mceniff NJ et al.: Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200: 185–192. MEDLINE |
| 19. | D`Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytic review. Hepatology 1995; 22: 332–354. MEDLINE |
| 20. | D´Amico G, Pietrosi G, Tarantino I, Pagliaro L: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: A Cochrane meta-analysis. Gastroenterol 2003; 124: 1277–1291. MEDLINE |
| 21. | De Francis R: Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatology 2000; 33: 846–852. MEDLINE |
| 22. | De Franchis R: Portal hypertension, proceedings of the third Baveno international consensus Workshop on definitions, methodology, and therapeutic strategies. Blackwell Science, London 2001. |
| 23. | Epstein M: Treatment of refractory ascites. N Engl J Med 1989; 321: 1675–1677. MEDLINE |
| 24. | Escorsell A, Bordas JM, Castaneda B et al.: Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000; 31: 1061–1067. MEDLINE |
| 25. | Feretis C, Dimopoulos C, Benakis P, Kalliakmanis B, Apostolidis N: N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 1995; 27: 355–357. MEDLINE |
| 26. | Feu F, Garcia-Pagan JC, Bosch J et al.: Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056–1059. MEDLINE |
| 27. | Fleig W: Prophylaxtic therapy for esophageal hemorrhage revisited. Surg Clin North Am 1990; 70: 463–474. MEDLINE |
| 28. | Forrest EH, Stanley AJ, Redhead DN, McGilchrist AJ, Hayes PC: Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996; 10: 801–806. MEDLINE |
| 29. | Franco D, Vons C, Traynor O, de Smadja C: Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Ann Surg 1988; 123: 987–991. MEDLINE |
| 30. | Garcia-Tsao G, Groszmann RJ, Fisher RL et al.: Portal pressure, presence of gastroesophageal varices, and variceal bleeding. Hepatology 1985; 5: 419–424. MEDLINE |
| 31. | Garcia-Villareal L, Martinez-Lagares F, Siebra A, Guevara C, Marrero JM, Jimenez E, Monescillo A et al.: Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999; 29: 27–32. MEDLINE |
| 32. | Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M: Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension. Comparison of emergency and elective interventions. Dig Dis Sci 1998; 43: 2463–2469. MEDLINE |
| 33. | Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M: Renal effects of transjugular intrahepatic portosystemic shunt in cirrhotics: Comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998; 28: 683–688. MEDLINE |
| 34. | Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J et al.: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493–1502. MEDLINE |
| 35. | Gines A, Escorsell A, Gines P et al.: Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229–236. MEDLINE |
| 36. | Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R et al.: Randomized trial comparing albumin, dextran, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002–1010. MEDLINE |
| 37. | Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Ruiz del Arbol L et al.: Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839–1847. MEDLINE |
| 38. | Götzsche PC: Somatostatin or octreotide for acute bleeding oesophageal varices [Cochrain Review]. In: The Cochrain Library, Issue 1, 2002. Oxford: Update Software. |
| 39. | Groupe d´Etude des Anastomoses Intra-Hepatique (Toulouse BLNCPF). TIPS versus sclerotherapy plus propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial [Abstract]. Hepatology 1995; 22(Suppl): 299A. |
| 40. | Gülberg V, Liß I, Bilzer M, Waggershauser T, Reiser M, Gerbes AL: Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion 2002; 66: 127–130. MEDLINE |
| 41. | Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T et al.: Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients. A randomized controlled trial. Scand J Gastroenterol 2002; 37: 338–343. MEDLINE |
| 42. | Haag K; Rössle M, Hauenstein KH et al.: Der transjuguläre intrahepatische portosystemische Stent-Shunt (TIPS) in der Notfallbehandlung der portalen Hypertension. Intensivmedizin 1993; 30: 479–483. |
| 43. | Haag K: Duplex sonographic evaluation before and after TIPS: monitoring of shunt function. In: Conn HO, Palmaz JC, Rösch J, Rössle M (eds.): Transjugular intrahepatic portosystemic shunts. Igaku-Shoin: New York, Tokio: 1996: 319–330. |
| 44. | Haskal ZJ: Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts. Radiology 1999; 213: 759–766. MEDLINE |
| 45. | Huonker M, YO Schumacher, Ochs A, Sorichter S, Keul J, Rössle M: Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. GUT 1999; 44: 743–748. MEDLINE |
| 46. | Imperiale TF, Chalasani N: A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001; 33: 802–807. MEDLINE |
| 47. | Jalan R, John TG, Redhead DN et al.: A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90: 1932–1937. MEDLINE |
| 48. | Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, MacGilchrist AJ et al.: A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997; 26: 1115–1122. MEDLINE |
| 49. | Laine L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Int Med 1995; 123: 280–287. MEDLINE |
| 50. | Lebrec D, Giuily N, Hadengue A, Vilgrain V, Lassen C, Poynard T: Transjugular intrahepatic portosystemic shunts – comparison with paracentesis in patients with cirrhosis and refractory ascites – a randomized trial. J Hepatol 1996; 25: 135–144. MEDLINE |
| 51. | Le Moine O, Deviere J, Ghysels M et al.: Transjugular intrahepatic portosystemic stent shunt as a rescue treatment after sclerotherapy failure in variceal bleeding. Scand J Gastroenterol, Suppl 1994; 207: 23–28. MEDLINE |
| 52. | Le Moine O, Nevens F, Deviere J et al.: TIPS for refractory ascites. A Belgian two-center experience. Hepatology 1996; 24: 445A. |
| 53. | Lo GH, Lai KH, Cheng JS et al.: A prospective, randomised trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060–1064. MEDLINE |
| 54. | Lo GH, Chen WC, Chen MH, Hsu PI, Lin CK, Tsai WL et al.: Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 728–734. MEDLINE |
| 55. | Luca A, D´Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized trials. Radiology 1999; 212: 411–21 MEDLINE |
| 56. | Martinet JP, Fenyves D, Legault L et al.: Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS) – a caution. Dig Dis Sci 1997; 42: 161–166. MEDLINE |
| 57. | McCormick PA, Dick R, Panagou EB et al.: Emergency transjugular intrahepatic portosystemic stent-shunting as salvage treatment for uncontrolled variceal bleeding. British J Surg 1994; 81: 1324–1327. MEDLINE |
| 58. | McCormick PA, Patch D, Greenslade L et al.: Clinical versus haemodynamic response to drugs in portal hypertension. J Hepatology 1998; 28: 1015–1019. MEDLINE |
| 59. | Merli M, Salerno F, Riggio O, De Franchis R, Fiaccadori F, Meddi P, Primignani M et al.: Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998; 27: 48–53. MEDLINE |
| 60. | Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al.: The management of ascites in cirrhosis: report of the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258–266. MEDLINE |
| 61. | Narahara Y, Kanazawe H, Kawamata H, Tada N, Saitoh H, Matsuzaka S et al.: A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 2001; 21: 189–198. MEDLINE |
| 62. | Nazarian GK, Bjarnason H, Dietz CA et al.: Refractory ascites – midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997; 205: 173–180. MEDLINE |
| 63. | Nevens F, Bustami R, Scheys I, Lessafre E, Fevery J: Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology 1998; 21: 15–19. MEDLINE |
| 64. | Nolte W, Wiltfang J, Schindler C, Münke H, Unterberg K, Zumhasch U et al.: Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998; 28: 1215–1225. MEDLINE |
| 65. | Ochs A, Rössle M, Haag K et al.: The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192–1197. MEDLINE |
| 66. | Ochs A, Haag K, Rössle M: TIPS for ascites- reply. N Engl J Med 1995; (Letter). |
| 67. | Orloff MJ: Pathogenesis and surgical treatment of intractable ascites associated with alcoholic cirrhosis. Ann N Y Acad Sci 1970; 170: 213–238. |
| 68. | Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK: Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for the prevention of variceal rebleeding: A meta-analysis. Hepatology 1999; 30: 612–622. MEDLINE |
| 69. | Patch D, Nikolopoulo V, McCormick A, Dick R, Armonis A, Wannamethee G, Burroughs AK: Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatology 1998; 28: 454–460. MEDLINE |
| 70. | Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C et al.: A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 1013–1019. MEDLINE |
| 71. | Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, Perreault P, Fenyves D et al.: Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in cirrhotic patients: a randomized trial. Gut 2001; 48: 390–396. MEDLINE |
| 72. | Quiroga J, Sangro B, Nunez M et al.: Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21: 986–994. MEDLINE |
| 73. | Rajan DK, Haskal ZJ, Clark TW: Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Intervent Radiol 2002; 13: 155–161. MEDLINE |
| 74. | Rössle M, Haag K, Ochs A et al.: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165–171. MEDLINE |
| 75. | Rössle M, Deibert P, Haag K et al.: Randomised trial of transjugular intrahepatic portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997; 349: 1043–1049. MEDLINE |
| 76. | Rössle M, Siegerstetter V, Huber M, Ochs A: The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18: 73–89. MEDLINE |
| 77. | Rössle M, Ochs A, Gülberg V, Siegerstetter V, Holl J, Deibert P, Olschewski M, Reiser M, Gerbes A: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701–1707. MEDLINE |
| 78. | Rössle M, Siegerstetter V, Olschewski M et al.: How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with a transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2001; 96: 3379–3383. MEDLINE |
| 79. | Rössle M: Prevention of rebleeding from oesophageal-gastric varices. Eur J Gastroenterol Hepatol 2001; 13: 343–348. MEDLINE |
| 80. | Rössle M, Siegerstetter V: Hepatic hydrothorax. Recommendations for rational therapy. (German). Dtsch Med Wochenschr 1998; 123: 1485–1489. MEDLINE |
| 81. | Rosemurgy AS, Goode SE, Zwiebel BR et al.: A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224: 378–386. MEDLINE |
| 82. | Runyon BA: Care of patients with ascites. N Engl J Med 1994; 330: 337–342. MEDLINE |
| 83. | Runyon BA: Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27: 264–272. MEDLINE |
| 84. | Sanyal AJ, Freedman AM, Luketic VA et al.: Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138–146. MEDLINE |
| 85. | Sanyal AJ, Freedman AM, Luketic VA, Purdum III PP, Shiffman ML, Cole PE, Tisnado J et al.: Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997; 126: 849–857. MEDLINE |
| 86. | Sanyal AJ, Genning C, Reddy RK, Wong F, Kowdley K, Benner K, McCashland T, North American Study for the Treatment of Refractory Ascites Group: The North American study for the treatment of refractory ascites. Gastroenterology 2003; 124: 634–641. MEDLINE |
| 87. | Sarfeh JJ, Rypins EB: Partial versus total portacaval shunt in alcoholic cirrhosis. Ann Surg 1994; 219: 353–361. MEDLINE |
| 88. | Sarin SK, Lahoti D, Saxena SP et al.: Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343–1349. MEDLINE |
| 89. | Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A: Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997; 113: 1623–1631. MEDLINE |
| 90. | Sauer P, Benz C, Theilmann L, Richter GM, Stremmel W, Stiehl A: Transjugular intrahepatic portosystemic stent-shunt (TIPS) vs endoscopic banding in the prevention of variceal rebleeding: final results of a randomized study [Abstract]. Gastroenterology 1998; 114: A1334. |
| 91. | Shellman R, Fulkerson W, De Long F, Piantadosi C: Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit. Crit Care Med 1988; 16: 671–678. MEDLINE |
| 92. | Siegerstetter V, Huber M, Ochs A, Blum HE, Rössle M: Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. Hepatology 1999; 29: 33–38. MEDLINE |
| 93. | Siegerstetter V, Deibert P, Ochs A et al.: Treatment of refractory hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13: 529–534.core MEDLINE |
| 94. | Soehendra N, Grimm H, Nam V, Berger B: N-butyl-2-cyanoacrylate : a supplement to endoscopic sclerotherapy. Endosc 1987; 19: 221–224. MEDLINE |
| 95. | Somberg K, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM: Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995; 21: 709–716. MEDLINE |
| 96. | Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ: Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997; 112: 473–482. MEDLINE |
| 97. | Teres J, Cecilia A, Bordas JM et al.: Oesophageal tamponade for bleeding varices. Gastroenterology 1978; 75: 566–569. MEDLINE |
| 98. | The North Italien Endoscopic Club for the Study and Treatment of Oesophageal Varices: Prediction of the first variceal haemorrhage in patients with cirrhosis of the liver and oesophageal varices. A prospective Multicenter Study. N Engl J Med 1988; 319: 983–989. MEDLINE |
| 99. | Tripathi D, Therapondos G, Jackson E et al.: The role of the transjugular intrahepatic portosystemic stent shunt [TIPSS] in the management of bleeding gastric varices: clinical and hemodynamic correlations. GUT 2002; 51: 270–274. MEDLINE |
| 100. | Trotter JF, Suhocki PV, Rockey DC: Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: Effect on body weight and Child-Pugh score. Am J Gastroenterol 1998; 93: 1891–1894. MEDLINE |
| 101. | Valeriano V, Salerno F, Merli M, Pozzi M, Borzio M, Cazzaniga M et al.: TIPS versus paracentesis in the treatment of refractory ascites: preliminary results of a randomized controlled trial. Gastroenterology 2000; 118: A1090. |
| 102. | Villanueva C, Minana J, Oritz J et al.: Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345: 647–655. MEDLINE |
| 103. | Wolff M, Kalff JC, Hirner A: Portosystemische Shuntchirurgie und transjugulärer intrahepatischer Stent (TIPS) in Deutschland. Der Chirurg 1999; 70: 447–452. MEDLINE |
| 104. | Wong F, Sniderman K, Liu P, Allidina J, Sherman M, Blendis LM: The effects of transjugular intrahepatic portosystemic shunt on systemic and renal hemodynamics and sodium hemostasis in cirrhotic patients with refractory ascites. Ann Int Med 1995; 122: 816–822. MEDLINE |
| 105. | Wong F, Sniderman K, Liu P, Blendis LM:. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997; 112: 988–907. MEDLINE |
| 106. | Wong W, Liu P, Blendis LM, Wong F: Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites. Am J Med 1999; 106: 315–322. MEDLINE |
